|
|
Mediwatch PLC - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for Mediwatch PLC. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Mediwatch PLC. The Group's principal activity is developing primary care products used in the diagnosis of urological disorders and early prostate cancer detection. Its operation focuses on such areas urology, bladder assessment, erectile dysfunction, urogynaecology, incontinence and near-patient testing. The Group operates in three divisions: ultrasound, urodynamics and biochemistry. Its products include Portascan+, Multiscan and Multiscan PVR in ultrasound; Urodyn 1000, Portaflow, Duet Logic G2, Duet Encompass and Duet Logic Sensic G3, Disposables and Erectease in urodynamics and PSAWatch, Bioscan and BTA in biochemistry. The Group operates predominantly in the United Kingdom.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|